← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #625 OF 1,000 MOST-CITED

Standard reference materials; criteria for selecting

FDA cited this observation 28 times across 24 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods28
BY FISCAL YEAR
FY20263
FY20259
FY20245
FY20231
FY20225
FY20213
FY20192

How FDA worded it — real examples

You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

Gemini Pharmaceuticals, Inc. · Commack, New York · Foods · 2026-05-15

You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

Herbalife International of America, Inc · Winston Salem, North Carolina · Foods · 2026-04-24

You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

Feral Fungi LLC · Estacada, Oregon · Foods · 2026-04-15

You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

Llorens Pharmaceuticals International Division, Inc. · Miami, Florida · Foods · 2025-09-26

You did not establish laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

NOW Health Group Inc. · Bloomingdale, Illinois · Foods · 2025-09-12

You did not establish and follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

Adept Life Sciences, LLC · Chandler, Arizona · Foods · 2025-08-27

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →